NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

VG Life Sciences Inc (PINK: VGLS)

 
VGLS Technical Analysis
1
As on 21st Nov 2024 VGLS STOCK Price closed @ 0.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VGLSSTOCK Price

Open 0.00 Change Price %
High 0.00 1 Day N/A N/A
Low 0.00 1 Week 0.00 0.00
Close 0.00 1 Month 0.00 0.00
Volume 22704200 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
PINK USA Most Active Stocks
TXGE 2496.74 -1.63%
CYBL 0.01 %
VGLS 0.00 %
HADV 0.00 %
PLPL 0.00 %
CLNV 0.02 0.00%
WRFX 0.01 %
CBTC 0.00 %
TMGI 0.00 %
AMXVF 1.05 10.53%
 
PINK USA Top Gainers Stocks
ANAV 12.05 30025.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
GPGC 0.40 3900.00%
JZRIF 0.15 1400.00%
YRLLF 0.10 900.00%
NZERD 0.36 800.00%
MMCWF 0.07 600.00%
CNQQF 0.23 360.00%
TDCH 0.60 275.00%
 
PINK USA Top Losers Stocks
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
FFVWF 0.01 -94.12%
PTHIF 0.10 -90.91%
PTHIF 0.10 -90.91%
GFDV 0.01 -88.89%
MINRF 0.05 -82.14%
KIRY 0.02 -80.00%
ATMS 0.50 -73.54%
GMSQF 0.03 -72.73%
 
 
VGLS
Daily Charts
VGLS
Intraday Charts
Whats New @
Bazaartrend
VGLS
Free Analysis
 
VGLS Important Levels Intraday
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
 
VGLS Forecast November 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
VGLS Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
VGLS Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
VGLS Other Details
Segment EQ
Market Capital 1127869.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VGLS Address
VGLS
 
VGLS Latest News
 
Your Comments and Response on VG Life Sciences Inc
 
VGLS Business Profile
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. Address: 121 Gray Avenue, Santa Barbara, CA, United States, 93101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service